A platform for collecting health data on ME/CFS and Long Covid
Official title: Unhide® Project Also Known as The Unhide® Solve Together Unified Platform
Run by Brain Inflammation Collaborative · NCT04806620 · Data updated 2026-11-12
This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Brain Inflammation Collaborative Academic / other |
| Locations | 1 site (Delafield, Wisconsin) |
| Status | Recruiting |
| Started | July 5, 2023 |
| Main results expected | June 30, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | January 22, 2026 |
| Trial ID | NCT04806620 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 18 and older with ME/CFS, Long Covid, or those without these conditions who wish to contribute to research.
✕Probably not a fit
Patients who are under 18 or do not have ME/CFS or Long Covid may not receive direct benefits from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Solve Together is an observational platform designed to gather clinical data on post-infectious diseases, particularly Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long Covid. Participants aged 18 and older can create profiles, complete surveys about their medical history and symptoms, and use a mobile app to track their health. The collected data will be anonymized and made available to researchers to enhance understanding of these conditions and support future clinical studies. This initiative aims to foster collaboration among patients, healthcare providers, and researchers.
Why it matters
Potential benefit: If successful, this platform could significantly enhance the understanding and treatment options for patients suffering from ME/CFS and Long Covid.
How similar studies have gone: While similar data collection approaches have been utilized, this specific platform is a novel initiative aimed at addressing the unique challenges of ME/CFS and Long Covid.
Who can join: the full rules
Show full inclusion / exclusion criteria
Participants may be either self-diagnosed, or diagnosed by a physician with the following conditions: * Infection-associated chronic conditions such as Long COVID, chronic Lyme, myalgic encephalomyelitis (ME/CFS), and post-acute neuropsychiatric syndrome (PANS/PANDAS). * Neuroimmune, developmental, autonomic, and neurological conditions like migraines, dysautonomia, POTS, multiple sclerosis, and autism spectrum disorder. * Autoimmune diseases such as Lupus, Sjogren's Disease, rheumatoid arthritis, myasthenia gravis, ankylosing spondylitis, and related autoimmune conditions. Inflammatory gastrointestinal conditions such as Crohn's Disease, Celiac Disease, and ulcerative colitis. * Behavioral and mood disorders such as anxiety, depression, bipolar disorder, PTSD, eating disorders, OCD, and other related conditions. * "Healthy" people (without brain inflammation), including unaffected individuals, unaffected individuals in the same household, and unaffected individuals who are married to relatives and family members. * Have consistent internet access and a cell phone, tablet, or PC since this is an online or app-based platform that requires entering data and completing surveys. * Currently live in the United States * Be able to participate in English (stay tuned for updates about the Spanish language version) * Be willing to share symptom and health data through the platform
Where it's running
-
Brain Inflammation Collaborative
Delafield, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Megan L Fitzgerald, PhD — Brain Inflammation Collaborative
- Study coordinator: Megan L Fitzgerald, PhD
- Email: help@braininflammationcollaborative.org
- Phone: 1-833-286-4433
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Cognitive evaluation for people with eating disorders
This project tests whether thinking skills (like cognitive flexibility and inhibitory control) and automatic food-related attitudes differ among people aged 14–65 with ARFID, anorexia, or bulimia.
-
Using deep rTMS to improve memory in Alzheimer's Disease
This study is testing if a new brain treatment called deep rTMS can help improve memory in people with mild to moderate Alzheimer's Disease.
-
Genetic study on eating disorders
This study is trying to understand the genetic and environmental causes of eating disorders by gathering information from 20,000 people with different eating disorders and healthy individuals.
-
Identifying biomarkers for autoimmune diseases affecting the nervous system
This study is trying to find specific markers in the blood of people with autoimmune diseases affecting the nervous system, like Multiple Sclerosis, to help with early diagnosis and better treatment options.
-
Immune signals and regulatory T cells in migraine
This research will test whether blood immune markers and regulatory T cells are linked to migraine in women ages 18–50 who have migraine or certain autoimmune/inflammatory conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.